Format
Sort by
Items per page

Send to

Choose Destination

Best matches for "adalimumab" AND ("Rheumatoid Arthritis" OR "Psoriatic Arthritis" OR "Ankylosing Spondylitis" OR "Crohn's disease" OR "Plaque Psoriasis" OR "adult moderate chronic plaque psoriasis" OR "severe chronic plaque psoriasis" OR "pediatric Crohn's disease" OR "moderately active polyarticular juvenile idiopathic arthritis" OR "severely active polyarticular juvenile idiopathic arthritis" OR "Rheumatoid Arthritis" OR "Psoriatic Arthritis" OR "Ankylosing Spondylitis" OR "Crohn's disease" OR "Plaque Psoriasis" OR "adult moderate chronic plaque psoriasis" OR "severe chronic plaque psoriasis"):

Search results

Items: 1 to 20 of 4737

  • Quoted phrase not found.
1.

Anti-interleukin-1 treatment in patients with rheumatoid arthritis and type 2 diabetes (TRACK): A multicentre, open-label, randomised controlled trial.

Ruscitti P, Masedu F, Alvaro S, Airò P, Battafarano N, Cantarini L, Cantatore FP, Carlino G, D'Abrosca V, Frassi M, Frediani B, Iacono D, Liakouli V, Maggio R, Mulè R, Pantano I, Prevete I, Sinigaglia L, Valenti M, Viapiana O, Cipriani P, Giacomelli R.

PLoS Med. 2019 Sep 12;16(9):e1002901. doi: 10.1371/journal.pmed.1002901. eCollection 2019 Sep.

2.

Interventions for maintenance of surgically induced remission in Crohn's disease: a network meta-analysis.

Iheozor-Ejiofor Z, Gordon M, Clegg A, Freeman SC, Gjuladin-Hellon T, MacDonald JK, Akobeng AK.

Cochrane Database Syst Rev. 2019 Sep 12;9:CD013210. doi: 10.1002/14651858.CD013210.pub2. [Epub ahead of print] Review.

PMID:
31513295
3.

Pedictors of Perianal Fistula Relapse in Crohn's Disease.

Malian A, Rivière P, Bouchard D, Pigot F, Eléouet-Kaplan M, Favreau-Weltzer C, Poullenot F, Laharie D.

Inflamm Bowel Dis. 2019 Aug 30. pii: izz200. doi: 10.1093/ibd/izz200. [Epub ahead of print]

PMID:
31504542
4.

Longitudinal trajectory of fatigue with initiation of biologic therapy in inflammatory bowel diseases: A prospective cohort study.

Borren NZ, Tan W, Colizzo FP, Luther J, Garber JJ, Khalili H, van der Woude CJ, Ananthakrishnan AN.

J Crohns Colitis. 2019 Aug 26. pii: jjz148. doi: 10.1093/ecco-jcc/jjz148. [Epub ahead of print]

PMID:
31504365
5.

Meta-analyses of Clinical Efficacy of Risankizumab and Adalimumab in Chronic Plaque Psoriasis: Supporting Evidence of Risankizumab Superiority.

Witjes H, Khatri A, Diderichsen PM, Mandema J, Othman AA.

Clin Pharmacol Ther. 2019 Sep 10. doi: 10.1002/cpt.1624. [Epub ahead of print]

PMID:
31502263
6.

Time to antibody detection and associated factors for presence of anti-drug antibodies in pediatric inflammatory bowel disease patients treated with anti-TNF therapy.

Moses J, Lambert-Jenkins K, Momotaz H, Sattar A, Debanne SM, Splawski J, Sferra TJ.

Eur J Gastroenterol Hepatol. 2019 Oct;31(10):1228-1233. doi: 10.1097/MEG.0000000000001538.

PMID:
31498282
7.

The effect of certolizumab drug concentration and anti-drug antibodies on TNF neutralisation.

Berkhout LC, Vogelzang EH, Hart MM, Loeff FC, Dijk L, Derksen NIL, Wieringa R, van Leeuwen WA, Krieckaert CLM, de Vries A, Nurmohamed MT, Wolbink GJ, Rispens T.

Clin Exp Rheumatol. 2019 Aug 30. [Epub ahead of print]

PMID:
31498069
8.

Nanoparticle-delivered siRNA targeting Bruton's tyrosine kinase for rheumatoid arthritis therapy.

Zhao G, Liu A, Zhang Y, Zuo ZQ, Cao ZT, Zhang HB, Xu CF, Wang J.

Biomater Sci. 2019 Sep 9. doi: 10.1039/c9bm01025d. [Epub ahead of print]

PMID:
31495833
9.

Effect of Baricitinib and Adalimumab in Reducing Pain and Improving Function in Patients with Rheumatoid Arthritis in Low Disease Activity: Exploratory Analyses from RA-BEAM.

Fautrel B, Kirkham B, Pope JE, Takeuchi T, Gaich C, Quebe A, Zhu B, de la Torre I, De Leonardis F, Taylor PC.

J Clin Med. 2019 Sep 5;8(9). pii: E1394. doi: 10.3390/jcm8091394.

10.

Different Original and Biosimilar TNF Inhibitors Similarly Reduce Joint Destruction in Rheumatoid Arthritis-A Network Meta-Analysis of 36 Randomized Controlled Trials.

Graudal N, Kaas-Hansen BS, Guski L, Hubeck-Graudal T, Welton NJ, Jürgens G.

Int J Mol Sci. 2019 Sep 5;20(18). pii: E4350. doi: 10.3390/ijms20184350. Review.

11.

Risk of cutaneous herpes zoster in patients with spondyloarthritis treated with conventional and biologic disease-modifying antirheumatic drugs.

Wong SCT, Li IWS, Ng AHY, Lau CS, Chung HY.

Int J Rheum Dis. 2019 Sep 6. doi: 10.1111/1756-185X.13694. [Epub ahead of print]

PMID:
31489783
12.

Weight Change in Patients with Psoriasis using Tumor Necrosis Factor-Alpha Inhibitors.

Muntyanu A, Gulliver WP, Fleming P.

Br J Dermatol. 2019 Sep 5. doi: 10.1111/bjd.18483. [Epub ahead of print]

PMID:
31487387
13.

Monocyte/Macrophage Abnormalities Specific to Rheumatoid Arthritis Are Linked to miR-155 and Are Differentially Modulated by Different TNF Inhibitors.

Paoletti A, Rohmer J, Ly B, Pascaud J, Rivière E, Seror R, Le Goff B, Nocturne G, Mariette X.

J Immunol. 2019 Sep 4. pii: ji1900386. doi: 10.4049/jimmunol.1900386. [Epub ahead of print]

PMID:
31484730
14.

Bilateral sub-deltoid bursitis in a patient receiving infliximab for Crohn's disease.

Bellakhal S, Abbes M, Jomni MT, Abdelaali I, Charfi M, Douggui MH.

Curr Drug Saf. 2019 Sep 4. doi: 10.2174/1574886314666190904115511. [Epub ahead of print]

PMID:
31483235
15.

Treatment of plaque psoriasis with IL-23p19 blockers: A systematic review and meta-analysis.

Xu S, Zhang X, Pan M, Shuai Z, Xu S, Pan F.

Int Immunopharmacol. 2019 Oct;75:105841. doi: 10.1016/j.intimp.2019.105841. Epub 2019 Aug 26.

PMID:
31465912
16.

Monitoring of Adalimumab Concentrations at Home in Patients with Inflammatory Bowel Disease using Dried Blood Samples.

Berends SE, Bloem K, de Vries A, Schaap T, Rispens T, Strik AS, Talwar R, Löwenberg M, D'Haens GR, Mathôt RA.

Ther Drug Monit. 2019 Aug 26. doi: 10.1097/FTD.0000000000000686. [Epub ahead of print]

PMID:
31464823
17.

Therapeutic Drug Monitoring to Guide Clinical Decision Making in Inflammatory Bowel Disease Patients with Loss of Response to Anti-TNF: A Delphi Technique-Based Consensus.

Greuter T, Maillard MH, Juillerat P, Michetti P, Seibold F, Mottet C, Zahnd N, Sauter B, Schoepfer AM, Rogler G, Vavricka SR; on behalf of the Swiss IBDnet, an official working group of the Swiss Society of Gastroenterology.

Digestion. 2019 Aug 28:1-9. doi: 10.1159/000501930. [Epub ahead of print]

PMID:
31461706
18.

Biologic therapies for Crohn's disease: optimising the old and maximising the new.

Samaan M, Campbell S, Cunningham G, Tamilarasan AG, Irving PM, McCartney S.

F1000Res. 2019 Jul 29;8. pii: F1000 Faculty Rev-1210. doi: 10.12688/f1000research.18902.1. eCollection 2019. Review.

19.

A case of psoriatic arthritis, with joint involvement preceding skin involvement, successfully treated with adalimumab (80 mg every other week).

Nanke Y, Kobashigawa T, Sugimoto N, Yamanaka H, Kotake S.

Immunol Med. 2019 Aug 25:1-4. doi: 10.1080/25785826.2019.1657255. [Epub ahead of print]

PMID:
31446856
20.

Small Bowel Healing Detected by Endoscopy in Patients With Crohn's Disease After Treatment With Antibodies Against Tumor Necrosis Factor.

Takenaka K, Fujii T, Suzuki K, Shimizu H, Motobayashi M, Hibiya S, Saito E, Nagahori M, Watanabe M, Ohtsuka K.

Clin Gastroenterol Hepatol. 2019 Aug 20. pii: S1542-3565(19)30899-7. doi: 10.1016/j.cgh.2019.08.024. [Epub ahead of print]

PMID:
31442600

Supplemental Content

Loading ...
Support Center